Q1 2019 Rigel Pharmaceuticals Inc Earnings Call Transcript
Good afternoon and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter of 2019. (Operator Instructions) I would like to remind you that this call is being recorded for replay purposes from Rigel's website. (Operator Instructions) And now I will turn this conference over to our first speaker, Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel.
Welcome to our financial results and business update conference call. The financial press release for the first quarter of 2019 was issued a short while ago and can be viewed, along with the accompanying slides for this presentation, in the news and events section of our Investor Relations page on our website at www.rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our financial outlook and our plans and timing for regulatory
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |